John chin, former general manager of Xinji China was appointed chief business officer of deqi pharmaceutical
-
Last Update: 2020-01-07
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On January 6, Deqi pharmaceutical announced the appointment of John chin as the chief business officer (CBO) to be responsible for the global expansion and business layout of the company's projects, and will report directly to the chairman and CEO of the company, Dr Mei Jianming Recent photos of John Chin Before joining Deqi, John chin served as general manager of celgene China, led the team of new base China, supported the development and application of new base products in China, and promoted the commercial operation and sales of products and Chinese partners Previously, John chin worked for BMS and Merck It is reported that Deqi pharmaceutical is an innovative pharmaceutical enterprise operating in the clinical stage in both China and the United States It focuses on solving unmet clinical needs through new drug development, clinical research, production and marketing.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
